SCHEMBL7550158

SCHEMBL7550158

CC(=O)c1cccc(NC(=O)N[C@@H]2CCC[C@@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1

nearest known ligand 0.97

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CCR3 P51677 20/20 0.97
CYP2D6 P10635 2/20 0.97
DRD2 P14416 1/20 0.97
SLC6A2 P23975 1/20 0.97
HTR2A P28223 1/20 0.97
SLC6A4 P31645 1/20 0.97
SLC6A3 Q01959 1/20 0.97
KCNH2 Q12809 1/20 0.97
CXCR1 P25024 1/20 0.70
CXCR2 P25025 1/20 0.70
CCR1 P32246 1/20 0.70
CCR2 P41597 1/20 0.70
CCR5 P51681 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6403335 0.98 CCR3 (1.00) CCR3CYP2D6DRD2SLC6A2HTR2A
SCHEMBL29372294 0.98 CCR3 (1.00) CCR3CYP2D6DRD2SLC6A2HTR2A
SCHEMBL18840907 0.98 CCR3 (1.00) CCR3CYP2D6DRD2SLC6A2HTR2A
Hydrochloric Acid SCHEMBL6421288 0.98 CCR3 (0.98) CCR3CYP2D6DRD2SLC6A2HTR2A
SCHEMBL6345562 0.92 CCR3 (0.85) CCR3CYP2D6DRD2SLC6A2HTR2A
SCHEMBL6348167 0.92 CCR3 (0.85) CCR3CYP2D6DRD2SLC6A2HTR2A
SCHEMBL6345564 0.92 CCR3 (0.85) CCR3CYP2D6DRD2SLC6A2HTR2A
SCHEMBL6348170 0.92 CCR3 (0.85) CCR3CYP2D6DRD2SLC6A2HTR2A
SCHEMBL1223759 0.92 CCR3 (0.87) CCR3CYP2D6DRD2SLC6A2HTR2A
SCHEMBL1223755 0.92 CCR3 (0.87) CCR3CYP2D6DRD2SLC6A2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1161240-A4 N-UREIDOALKYL-PIPERIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY DU PONT PHARM CO (US) 2002-04-03 EP claimed
EP-1161240-A1 N-UREIDOALKYL-PIPERIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY Du Pont Pharmaceuticals Company (US) 2001-12-12 EP claimed
WO-2000035452-A1 N-UREIDOALKYL-PIPERIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY DU PONT PHARMACEUTICALS COMPANY (US) 2000-06-22 WO claimed